ABLE conducts BEST entrepreneurial workshop for young postgraduates in Manesar

2017-02-21 06:30:38

Twenty student teams participate in entrepreneurship program conducted by ABLE. To present their business ideas in 20 minutes to a jury at the end of the workshop on February 22, 2017.By Team ABLEEighth edition of the Biotechnology Enterpreneurship  Student Team (BEST) \four-day workshop gets started in Manesar, National Capital Region. BEST is aimed at encouraging young postgraduate and doct

Read more

National Regulatory Authority of India meets WHO international standards for vaccine regulations

2017-02-21 05:16:24

The National Regulatory Authority of India (NRA) has announced that the regulatory body and affiliated institutions meet the WHO Global Benchmarking Tool requirements for a functional vaccine regulatory system. By Team ABLEThe National Regulatory Authority of India (NRA) has announced that the regulatory body and affiliated institutions meet the WHO Global Benchmarking Tool requirements for a func

Read more

Union Minister for Health and Family Welfare J P Nadda wows to protect every child in the country from vaccine preventable diseases

2017-02-21 05:13:16

Appreciating the plan of expansion of Rotavirus vaccine in Tripura, J P Nadda, Union Minister for Health and Family Welfare announced the expansion of the Rotavirus vaccine under its Universal Immunization Programme in five additional states in a function at AgartalaBy Team ABLE“It is our endeavour to protect each and every child in the country from vaccine preventable diseases. This is a new mi

Read more

Serum Institute, Cipla launch Hepatitis B vaccine in India

2017-02-21 05:11:08

Under a co-exclusive agreement with Serum Institute of India (SII), global pharmaceutical company Cipla has launched adult Hepatitis B vaccine in India.  By Team ABLEUnder a co-exclusive agreement with Serum Institute of India (SII), global pharmaceutical company Cipla has launched adult Hepatitis B vaccine in India. Cipla will market the vaccine for adults while SII will market it for adults

Read more

Monash University extends its ‘Eliminate Dengue’ global program to ICMR

2017-02-21 04:33:54

In partnership with the Indian Council of Medical Research (ICMR), Eliminate Dengue Program (EDP) led from Monash University, aims to work with the Indian Government to find a sustainable solution to mosquito-borne viruses.By Team ABLEThe Eliminate Dengue Program (EDP) led from Monash University, has recently announced a new project in India to combat dengue and other mosquito-borne diseases using

Read more

Kemwell clears USFDA inspection at Bengaluru facility

2017-02-21 04:30:46

According to the press release, the inspection confirmed the Bengaluru facility to be compliant with principles of current Good Manufacturing Practices (cGMPs) and no Form 483 observations were issued.By Team ABLEKemwell Biopharma, a global bio/pharmaceutical contract development and manufacturing company, has announced that its oral solids manufacturing facility located in Bengaluru, India has su

Read more

DBT calls for Concept Notes under Biotechnology Based Program for Societal Development

2017-02-18 08:40:52

The Department of Biotechnology is implementing a scheme on “Biotechnology Based Program for Societal Development” for the socio-economic upliftment of SC/STBy Team ABLEThe Department of Biotechnology is implementing a scheme on “Biotechnology Based Program for Societal Development” for the socio-economic upliftment of SC/ST, Rural community and women. The priorities of the program are ide

Read more

BIRAC Announces 40th Call for Proposals under BIPP Scheme

2017-02-18 08:39:43

The Biotechnology Industry Research Assistance Council (BIRAC) has called for proposals for product development from MSMEs, Start-Ups and other manufacturing industries.By Team ABLEThe Biotechnology Industry Research Assistance Council (BIRAC) has called for proposals for product development from MSMEs, Start-Ups and other manufacturing industries. The proposals have been invited under two program

Read more

US FDA accepts BLA for review of Mylan-Biocon's proposed neutropenia biosimilar

2017-02-18 08:05:18

Mylan N V and Biocon have announced that the US FDA has accepted Mylan\'s BLA for MYL-1401H, a proposed biosimilar to Neulasta (pegfilgrastim), which is used to reduce the duration of neutropenia By Team ABLEGlobally-renowned biosimilar manufacturers, Mylan N V and Biocon have announced that the US Food and Drug Administration (FDA) has accepted Mylan\'s Biologics License Application (BLA) for MYL

Read more

DBT calls for proposal under Newton Fund: DBT-DFID-ESRC-MRC Global Research Program

2017-02-18 08:03:35

DBT has announced a second joint call to fund global health research addressing the health needs of women and children globallyBy Team ABLEThe Department of Biotechnology (DBT) in India, in collaboration with Department of International Development (DFID), the Economic and Social Research Council (ESRC) and the Medical Research Council (MRC), have announced a second joint call to fund global healt

Read more